MARKET

FLGT

FLGT

Fulgent Genetics
NASDAQ
26.27
-0.22
-0.83%
After Hours: 25.84 -0.43 -1.64% 19:52 12/31 EST
OPEN
26.49
PREV CLOSE
26.49
HIGH
26.55
LOW
26.10
VOLUME
174.79K
TURNOVER
--
52 WEEK HIGH
31.04
52 WEEK LOW
14.57
MARKET CAP
812.07M
P/E (TTM)
-18.7429
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at FLGT last week (1222-1226)?
Weekly Report · 12/29/2025 09:49
FLGT to Acquire Bako & StrataDx Assets to Expand Pathology Platform
NASDAQ · 12/23/2025 17:35
Fulgent Genetics to Acquire Assets From Bako, StrataDx for $55.5M
Dow Jones · 12/22/2025 22:21
Fulgent Genetics expands diagnostics with major dermatopathology deals
TipRanks · 12/22/2025 21:33
Fulgent Genetics to acquire Bako Diagnostics and StrataDx
TipRanks · 12/22/2025 21:15
Fulgent Genetics to Acquire Bako Diagnostics and StrataDx for $55.5 Million
Reuters · 12/22/2025 21:10
FULGENT GENETICS INC - TO BUY BAKO AND STRATADX FOR $55.5 MLN
Reuters · 12/22/2025 21:10
Press Release: Fulgent Genetics Agrees to Acquire Bako Diagnostics and StrataDx
Dow Jones · 12/22/2025 21:10
More
About FLGT
Fulgent Genetics, Inc. is a technology-based company with a laboratory services business and a therapeutic development business. Its laboratory services business includes technical laboratory and testing services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a range of cancers using a novel nanoencapsulation and targeted therapy platform designed to improve the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. Its testing services include comprehensive anatomic pathology testing services, including gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology, and precision diagnostics testing services, including next-generation sequencing (NGS), tests for biopharma research and clinical tests for rare disease, hereditary cancer, reproductive health, and many other diseases.

Webull offers Fulgent Genetics Inc stock information, including NASDAQ: FLGT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FLGT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading FLGT stock methods without spending real money on the virtual paper trading platform.